Petrovax changes packaging design for Polyoxidonium

Petrovax has redesigned the packaging for its proprietary drug Polyoxidonium® to provide consumers with a brighter, more user-friendly, and informative design. The redesigned packaging has been implemented for all currently available dosage forms of the drug, which include tablets, solutions for injection and topical application, suppositories, and lyophilized powder. The 6 mg pediatric suppositories now feature additional visual accents to distinguish them from other dosage forms. The hexagonal element in the new design symbolizes not only the protection provided to the body but also the "charge" given to the immune system.

Some pharmacies have already begun to stock Polyoxidonium® in the updated packaging; however, the drug will continue to be available in the previous packaging until existing supplies are exhausted.

Petrovax continues to follow modern trends in marketing and communications, employing innovative approaches to enhance interaction with consumers. An updated packaging design is not merely a step towards modernity but, above all, a way for us to demonstrate our care for consumers.

Polyoxidonium®, an original drug developed by Petrovax, is indicated for the prevention and treatment of infectious and inflammatory diseases across a wide range of medical specialties, including immunology, pediatrics, general medicine, gynecology, urology, and others.